by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersLaboratorios Jaloma S.A. de C.V.

All Warning Letters

Laboratorios Jaloma S.A. de C.V.

Warning LetterOpen

Calle Emiliano Zapata, No. 422 Oblatos 44380 Guadalajara , Jal. MexicoFEI 3002600322Issued May 22, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3002600322.

Violations5

Issue DateMay 22, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Laboratorios Jaloma S.A. de C.V.
Location: Calle Emiliano Zapata, No. 422 Oblatos 44380 Guadalajara , Jal. Mexico
FEI Number: 3002600322
Country: Mexico
Issue Date: May 22, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

CGMP/OTC/Finished Pharmaceuticals/Adulterated

Laboratorios Jaloma S.A. de C.V. FDA Warning Letter, May 22, 2026